Literature DB >> 31895241

The risk and prevention of sudden death in patients with heart failure with reduced ejection fraction.

Jason Davis1, John Sapp.   

Abstract

PURPOSE OF REVIEW: Patients with heart failure are at increased risk of sudden cardiac death. The methods to predict patients at high risk of sudden cardiac death in heart failure are neither sensitive nor specific; both overestimating risk in those with ejection fractions less than 35% and not identifying those at risk with ejection fractions greater than 35%. RECENT
FINDINGS: The absolute risk of sudden cardiac death in patients with heart failure have decreased over the past 20 years. New novel tools are being developed and tested to identify those at higher risk of sudden cardiac death. Reduction in the risk of sudden cardiac death has been achieved with the use of beta-blockers, spironolactone, sacubitril-valsartan, cardiac resynchronization and implantable cardioverter defibrillators.
SUMMARY: The use of contemporary treatments for patients with heart failure can reduce the risk of sudden cardiac death, but research is required to identify those at highest risk.

Entities:  

Mesh:

Year:  2020        PMID: 31895241     DOI: 10.1097/HCO.0000000000000710

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  3 in total

1.  Sacubitril/valsartan versus angiotensin inhibitors and arrhythmia endpoints in heart failure with reduced ejection fraction.

Authors:  Amanda D F Fernandes; Gilson C Fernandes; Caique M P Ternes; Rhanderson Cardoso; Sandra V Chaparro; Jeffrey J Goldberger
Journal:  Heart Rhythm O2       Date:  2021-12-17

2.  Association of time-varying changes in physical activity with cardiac death and all-cause mortality after ICD or CRT-D implantation.

Authors:  Xue-Rong Sun; Chen-Di Cheng; Bin Zhou; Shuang Zhao; Ke-Ping Chen; Wei Hua; Yan-Gang Su; Wei Xu; Fang Wang; Xiao-Han Fan; Yan Dai; Zhi-Min Liu; Shu Zhang
Journal:  J Geriatr Cardiol       Date:  2022-03-28       Impact factor: 3.327

Review 3.  The Impact of Angiotensin Receptor-Neprilysin Inhibitors on Arrhythmias in Patients with Heart Failure: A Systematic Review and Meta-analysis.

Authors:  Hata Mujadzic; George S Prousi; Rebecca Napier; Sultan Siddique; Ninad Zaman
Journal:  J Innov Card Rhythm Manag       Date:  2022-09-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.